NDC 61919-852

AMOLDIPINE BENAZEPRIL HCL

Amoldipine Benazepril Hcl

AMOLDIPINE BENAZEPRIL HCL is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Directrx. The primary component is Amlodipine Besylate; Benazepril Hydrochloride.

• Product ID: 61919-852_871e47cb-a829-9ba7-e053-2991aa0a96ea
• NDC: 61919-852
• Product Type: Human Prescription Drug
• Proprietary Name: AMOLDIPINE BENAZEPRIL HCL
• Generic Name: Amoldipine Benazepril Hcl
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2019-04-22
• Marketing Category: ANDA / ANDA
• Application Number: ANDA202239
• Labeler Name: DirectRX
• Substance Name: AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
• Active Ingredient Strength: 10 mg/1; mg/1
• Pharm Classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61919-852-90

90 CAPSULE in 1 BOTTLE (61919-852-90)

• Marketing Start Date: 2019-04-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61919-852-90 [61919085290]

AMOLDIPINE BENAZEPRIL HCL CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA202239
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-04-22

Drug Details

Active Ingredients

Ingredient	Strength
AMLODIPINE BESYLATE	10 mg/1

OpenFDA Data

• SPL SET ID: 871e47cb-a828-9ba7-e053-2991aa0a96ea
• Manufacturer:
  • DirectRX
• UNII:
  • 864V2Q084H
  • N1SN99T69T

Pharmacological Class

• Calcium Channel Antagonists [MoA]
• Dihydropyridine Calcium Channel Blocker [EPC]
• Dihydropyridines [CS]
• Angiotensin Converting Enzyme Inhibitor [EPC]
• Angiotensin-converting Enzyme Inhibitors [MoA]
• Decreased Blood Pressure [PE]
• Calcium Channel Antagonists [MoA]
• Dihydropyridine Calcium Channel Blocker [EPC]
• Dihydropyridines [CS]
• Angiotensin Converting Enzyme Inhibitor [EPC]
• Angiotensin-converting Enzyme Inhibitors [MoA]
• Decreased Blood Pressure [PE]